Cyclacel Pharmaceuticals, Inc. (CYCCP) - Latest Market Data

Track the most recent price, market cap, volume, and performance data for Cyclacel Pharmaceuticals, Inc. (CYCCP).

Download PennyGems on Google Play Download PennyGems on the App Store

Equity Overview

Price & Market Data

Price: $4.28

Daily Change: +$0.22 / 5.14%

Daily Range: $4.04 - $4.36

Market Cap: $8,138,292

Daily Volume: 801

Details

Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops cancer medicines based on cell cycle, transcriptional regulation, epigenetics, and mitosis control biology in the United States. Its lead product Plogosertib or plogo, a solid tumors and hematological malignancies, which is in Phase 1/2 clinical trial. The company was founded in 1996 and is headquartered in Kuala Lumpur, Malaysia.

Selected stocks

Immunic, Inc. (IMUX)

Catheter Precision, Inc. (VTAK)

ClearSign Technologies Corporation (CLIR)